Viroclinics

Rotterdam, Netherlands Founded: 2001 • Age: 25 yrs Acquired By Cerba HealthCare
Provider of preclinical and clinical trial services for vaccines, viral infections and related diagnostics

About Viroclinics

Viroclinics is a company based in Rotterdam (Netherlands) founded in 2001 by Albert Osterhaus was acquired by Cerba HealthCare in December 2021.. Viroclinics has completed 1 acquisition, including DDL Diagnostic Laboratory. Viroclinics operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.

  • Headquarter Rotterdam, Netherlands
  • Founders Albert Osterhaus
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Viroclinics
Headcount 1-10
Employee Profiles 26
Employee Profiles
People
Krijn Leeuwis
Technician
People
Robin Schotborgh Msc Ra
Director Finance
People
Djunita Gielen
Assistant Business Controller
People
Thomas Koelink
Senior Laboratoriumtechnicus

Unlock access to complete

Funding Insights of Viroclinics

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $1.0M
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2020 Amount Grant - Viroclinics Valuation

investors

Mar, 2020 Amount Series C - Viroclinics Valuation Summit Partners
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Viroclinics

Viroclinics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Cerba HealthCare and Summit Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Summit Partners is recognized as a growth equity investment firm.
Founded Year Domain Location
Private equity and venture captial firm focused on healthcare sectors
Founded Year Domain Location
Parcom is engaged as a Dutch investment company.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Viroclinics

Viroclinics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DDL Diagnostic Laboratory. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Molecular diagnostics testing and assay development services are offered.
1994
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Viroclinics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Viroclinics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Viroclinics

Viroclinics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of drug discovery and preclinical development services
domain founded_year HQ Location
Provider of laboratory tests for physicians
domain founded_year HQ Location
Data analysis and statistical solutions are provided for life sciences.
domain founded_year HQ Location
Provider of clinical research, development, and commercialization services for life sciences
domain founded_year HQ Location
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
domain founded_year HQ Location
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Viroclinics

When was Viroclinics founded?

Viroclinics was founded in 2001 and raised its 1st funding round 19 years after it was founded.

Where is Viroclinics located?

Viroclinics is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.

Who is the current CEO of Viroclinics?

Davide Molho is the current CEO of Viroclinics.

What does Viroclinics do?

Viroclinics Biosciences, a spin-off from the Viroscience Lab at the Erasmus Medical Centre in Rotterdam, the Netherlands, is a provider of preclinical and clinical trial services for the development of vaccines, antiviral drugs, and diagnostics. They can offer their services from new drug development programs to right until post-marketing surveillance of existing drugs and vaccines, and also includes traditional virology assays and latest deep sequencing protocols for a range of viruses. They have BSL2 and BSL3 labs which are ISO 15189 accredited.

Who are the top competitors of Viroclinics?

Viroclinics's top competitors include LabCorp, Charles River Laboratories and Cytel.

How many acquisitions has Viroclinics made?

Viroclinics has made 1 acquisition, including DDL Diagnostic Laboratory.

Who are Viroclinics's investors?

Viroclinics has 5 investors. Key investors include European Union, Cerba HealthCare, Summit Partners, Gilde Healthcare, and Parcom.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available